chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Her arm was killing her; couldn't function; She was down; This case was reported by a consumer via and described the occurrence of pain in arm in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than 6 months after receiving Shingrix, the patient experienced pain in arm, mobility decreased and unwell. On an unknown date, the outcome of the pain in arm, mobility decreased and unwell were unknown.   It was unknown if the reporter considered the pain in arm, mobility decreased and unwell to be related to Shingrix.  Additional details were reported as follows: The case was reported by the friend of the patient. The age at vaccination was not reported. The patient had 2nd dose shot a few weeks prior and the patient was down. The patient arm was killing her and the patient could not function. The reporter did not consent to follow up. The reporter declined to provide additional information.
bruised at the injection site; injection site was red; swollen about two inches across; muscle feels softer/arm is fleshy in the spot, like the muscle tissue broke down.; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 17Apr2021 at 15:30 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Medical history included thalassemia minor and psoriasis. The patient received birth control pills within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had not received any other vaccines within four weeks prior to COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 18Apr2021 at 17:00, her arm was still bruised at the injection site and the muscle feels softer, like a dent in the arm. A day after the injection, the injection site was red and swollen, about two inches across. It took more than a week for the swelling to go down, and now her arm was fleshy in that spot, like the muscle tissue broke down. The patient reports that she has symptoms even after nearly three weeks. The clinical outcome of the events bruised at injection site, injection site was red, swollen about two inches across, muscle feels softer and fleshy in that spot were not resolved at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.  Amendment: This follow-up report is being submitted to amend previously reported information: Vaccine Facility Information added, treatment received for all events updated to No, Event Vaccination site reaction removed since not specified, Event muscle feels softer/arm is fleshy in the spot, like the muscle tissue broke down was recoded as myalgia.
patient had been administered dose while the temperature excursion assessment was ongoing (possible temperature excursion); patient had been administered dose while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (patient had been administered dose while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patient had been administered dose while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 30-year-old female patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) .5 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (patient had been administered dose while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patient had been administered dose while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (patient had been administered dose while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patient had been administered dose while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   The reporter was an internal medicine manager.  Concomitant medication of the patient was not reported.  The reporter reported that because their facility had not been able to download the digital data logger, they had been put on hold by the State at the moment and cannot administer the Moderna COVID-19 vaccine to patients until an assessment by the state was made. There had been no power outages that would have impacted the Moderna vaccine. However, the reporter reiterated that because the facility was unable to download the digital data logger, this issue was treated as a temperature excursion. The reporter was unable to download the data logger for the months of December 2021, January 2022 and February 2022. The reporter was filling out a temperature excursion assessment with the State.   The reporter mentioned that the patient had been administered dose while the temperature excursion assessment was ongoing. The reporter also reported that, no adverse reactions were reported by the patient.  No treatment information was provided by the reporter.
Pt c/o metallic taste in mouth with numbness and tingling in the lower jaw and at finger tips accompanied with dizziness.
pt recv vax 29APR98 in lt arm; mom noticed lt arm swelling later 30APR98 firm top of shoulder to elbow & also hot to touch;was seen by MD 1MAY98 & given ATB;BY 6MAY98 swelling disappeared;
sleepiness, malaise, pallor, bruising @ the site, loss of endurance, dec energy, anorexia onset w/in 12 hrs of vax lasting 2 wks;treated w/Pred- inc appetite, energy dec still pale
swollen left leg; muscle soreness; cramping leg and knee; medium discomfort; extreme discomfort with left knee, treated as arthritis; This is spontaneous report from a contactable consumer (patient). This case is for first dose. An elderly non-pregnant female patient received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 MRNA VACCINE; Solution for injection (Batch/Lot Number: EWO175), dose 1 via an unspecified route of administration, administered in Arm Left on 30Apr2021 10:30 as a single dose for covid-19 immunisation. Medical history included hypertension, age related blood pressure, asthma, drug hypersensitivity. The patient's concomitant medications were not reported. The patient had no other vaccine within four weeks and no other medications received within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. It was reported that, after administration of first dose the patient had swollen left leg, muscle soreness, cramping leg and knee, medium discomfort, then extreme discomfort with left knee, treated as arthritis. The patient did not receive any treatment. The outcome of the events was not recovered. Device Date was 03May2021  No follow-up attempts are needed. No further information is expected.
Patient got up from being in bed in the AM and noticed some numbness/tingling in bilateral extremities. There was concern for stroke so the patient came to the ER .The patient had received the second dose of the Pfizer vaccination 2 days prior. The patient received tPA and was treated in the ICU. After a short hospital course, the patient was discharged home.
4 months of: Severe malaise and fatigue Persistent low-grade fever Sore throat Sore tonsils Muscle ache Joint ache Brain fog Ear ringing Night sweats Cough Heart palpitations
UrticariaPruritis From pt's physician "...Fridy 01/15/2021 due to delayed reaction to COVID-19 vaccination resulting in hives and requiring steroid treatment."
I began experiencing raised rashes and hives all over my body starting less than 2 weeks after I got my first covid booster shot. It appeared on my face, torso, arms, legs, palms, back, soles of my feet, etc. Every inch of my body. It was incredibly itchy to the point that I was not able to concentrate on anything else. The rashes were raised and looked as though I had been scratching at myself, even though I hadn't touched my skin. It especially worsened after a shower, even if I didn't use any products on myself. I was put on steroids for a couple weeks and changed my diet in hopes of treating it, but nothing helped. I then was put on Allegra and Claritin 2x a day, which then minimized the appearance of the hives and brought down the itching to the point that it was barely noticeable. However, as soon as I wait a little too long before taking the next pill, the itching comes back and the hives spread - it has now been almost 4 months with no sign of it going away.
running nose; low grade cold; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (running nose), NASOPHARYNGITIS (low grade cold) and FATIGUE (fatigue) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025C21A and 037B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-May-2021, the patient experienced NASAL CONGESTION (running nose), NASOPHARYNGITIS (low grade cold) and FATIGUE (fatigue). At the time of the report, NASAL CONGESTION (running nose), NASOPHARYNGITIS (low grade cold) and FATIGUE (fatigue) outcome was unknown.
Cellulitis; huge hives; Sore arm; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CELLULITIS (Cellulitis) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history) since an unknown date.    On 28-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, the patient experienced MYALGIA (Sore arm). On 04-Apr-2021, the patient experienced CELLULITIS (Cellulitis) (seriousness criterion medically significant) and URTICARIA (huge hives). In March 2021, MYALGIA (Sore arm) had resolved. At the time of the report, CELLULITIS (Cellulitis) and URTICARIA (huge hives) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient had a sore arm after vaccination.  A week later she developed huge hives and was diagnosed with cellulitis in her left arm at the doctor's office.   No concomitant medications were reported.  Treatment included doxycycline 100 mg.  Based on the information provided to include the location (Left arm-same as injected arm) and the onsets of the reported events, a causal association between the administration of mRNA-1273 and the events cannot be excluded.; Sender's Comments: Based on the information provided to include the location (Left arm-same as injected arm) and the onsets of the reported events, a causal association between the administration of mRNA-1273 and the events cannot be excluded.
Vomiting. She threw up 3 substantial times and then 4 more with an empty stomach, so more of dry heaving. This went on until 3:30 am. no fever and no other symptoms.
After third dose she also have a raise of her blood pressure/raising blood pressure after getting every shot of  the Moderna covid19 vaccine; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (After third dose she also have a raise of her blood pressure/raising blood pressure after getting every shot of  the Moderna covid19 vaccine) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004F21A, 027K20A and 025L20A) for COVID-19 vaccination.     The patient was not tested positive or diagnosed for COVID-19.  Concurrent medical conditions included Drug allergy (Epinephrine allergy), Diabetes since 2002 and Immunocompromised. Concomitant products included INSULIN, METFORMIN, ASCORBIC ACID, BETACAROTENE, CUPRIC OXIDE, TOCOPHERYL ACETATE, ZINC OXIDE (PRESERVISION), LEVOTHYROXINE, INSULIN DETEMIR (LEVEMIR), INSULIN ASPART (NOVOLOG), ZOLPIDEM and ALPRAZOLAM for an unknown indication.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On an unknown date, the patient experienced HYPERTENSION (After third dose she also have a raise of her blood pressure/raising blood pressure after getting every shot of  the Moderna covid19 vaccine). At the time of the report, HYPERTENSION (After third dose she also have a raise of her blood pressure/raising blood pressure after getting every shot of  the Moderna covid19 vaccine) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: raised (High) Raise of her blood pressure.         Concomitant medications included unspecified thyroid medication. It was reported that patient had a recent change in diabetes, it goes up an down,8.3 was the last one, and last year she did not have any 8.3. No other vaccines given within 1 month prior to Moderna COVID-19 vaccine. It was reported that in her vaccination card it was marked as a booster and her symptoms improved. No treatment information was provided.   This case was linked to MOD-2022-543442, MOD-2021-021010 (Patient Link).
pt recvd vax & exp arthralgias of the joints, hands, wrists & shoulders & myalgia; There was low grade aching w/intermittent flares; occasional adenopathy devel on 4FEB94; sx preculuded nl dialy activities; exercise of swimming was a proble
Student fainted after getting the MMR vaccine today.  Mom said student is afraid of needle and said that once student saw the needle when I was disposing of it, she got scared and fainted.  No loss of consciousness, no difficulty breathing, no head injury, no rashes.  Vitals are stable except BP slightly low at 70/60 checked twice.  After the incident mom and aunt reports that student has been complaining of feeling dizzy for the last few days.  Reports that appetite is good, and already had lunch today.  Sat with student, and gave water and monitor student for at least 30 minutes.  Student was alert, awake but slightly lethargic initially but was crying and talking.  Student was referred to be evaluated by doctor.  Sent to ER since student still complaining of feeling dizzy and does not have any health insurance and had just arrived to the country 15 days ago and no previous physical exam in foreign country.
Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 16-Jul-2022; No adverse event; Patient administered the vaccine after the 30 day by used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 16-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 59-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 16-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 day by used). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 16-Jul-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 16-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 day by used) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 16-Jul-2022).    No concomitant product use was reported.  Patient received half dose.  Vial did not undergone any temperature excursions.  No treatment information was provided.
arm got sore; This is a spontaneous report from a contactable nurse (wife). A 76-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/lot number and expiration date were not reported), via an unspecified route of administration on 21Feb2021 as dose number 2, single for COVID-19 immunisation. Medical history included anemic from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient was previously vaccinated with the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 13Jan2021 as dose 1, single for COVID-19 immunisation and experienced rashes all over/ shingles/all red, vomiting, headache, stomach upset, looking really sickly and scar was a little bit deep and brown. The patient experienced his arm got sore on an unspecified date. The outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
On 6/20/2021, had a very sudden onset of muscle pain in left calf, then right calf & both thighs while hiking. Cut hike short because of malaise. Had to sit down & vomit. Difficulty breathing, racing heart. That night, more nausea & vomiting after climbing up into the bunk bed of my RV. Breathing issues whenever I would take more than 2 steps. On 7/21/2021, climbed up in the bunk & had nausea, great difficulty breathing with wheezing, & chest felt like it was in a very painful vise. 7/26/2021 went to urgent care where pulmonary embolisms in both lungs were confirmed (saddle embolism & many smaller embolisms in both lungs). Ambulance to Hospital for 2 nights.
Patient received his vaccine shortly after 5pm and was transitioned to the observation area in front of the pharmacy. Shortly after he sat down in the observation chair another employee noticed that he started having a reaction and became unconscious. 2 individuals came over to help Pt. When they arrived, he was sliding down the chair and became conscious but was not talking. lowered patient to floor and administered an Epi Pen at 5:07.called 911. After patient regained consciousness, he seemed stable and did not recall knowing what happened and did not display any additional signs of an adverse reaction. EMS arrived and checked his vitals and Pt was given the option to go to the hospital or go home. Pt refused to go to hospital and was given a ride home.
Erythema, calor and edema at and extending inferiorly from the injection site  Ice packs  Follow up if not improving after 1 week
Mother reports child spent 3 hrs with father on 3/24/2010.  Upon return home, child had rash to back of neck and right arm.  Child left with father at 6 PM on 3/24 & returned at 9 PM.  No rash when he left, but rash upon his return.  Dr. notified.  Child received HEPA, DTP, & HIB on 3/23/10.
He received AVA # 1 on 26 Feb 00 and he reported that his arm became sore with slight swelling and he had flu like symptoms for a couple of days. He also reported that he felt fatigued did not fully resolve. He received AVA # 2 on 11 Mar 00 and he does not recall anything out of the ordinary only that his fatigue persisted, and again reported the same with AVA # 3 on 23 Mar 00. He does not recall any immediate worsening of the fatigue. Three to four months after AVA # 3 he began to notice problems with anxiety and depression. He denied any changes in his life at that time and he denied stress. He sought medical attention in Aug 2000 and began treatment. He denied any past problems with anxiety or depression. He began to notice problems with his PT in Sep in that he found it difficult to complete and he felt worse following his PT. He reported he was previously in good shape and now he later that fall he failed his PT. He was on PMPQ status while being treated with antidepressants. He felt that the medication did not work and felt that it made him more anxious. He was beginning to gain weight and was unable to loose wt despite running 1-2 miles 1-2 times weekly. In late 2003 he was diagnosed with hypogonadism. He did have a daughter in June 2002. He started noticing severe fatigue over the last 2-3 yrs and began feeling tired at work. He had spent 9 yrs working the night shift with every Tuesday and Saturday night off. He stated that he always felt tired while working the night shift during the nine years. While he was deployed he worked the day shift. He would go to bed at 11pm, fall and stay asleep until he woke up at 5:30 am. He stated he felt refreshed when he awoken. He stated he could not do his full PT because he could not keep up with the level of intensity due to his decrease testosterone. He did state that he felt tired but stated he was getting enough rest. He stated that his fatigue increased after exercise. He returned from his deployment in Apr 06 and for one week he worked an evening shift from 1830-0130. He noticed he had problems staying awake and felt himself becoming more tired. He had reduce his hours because of the fatigue. He did not work much during the month of May because on ongoing medical exams. He currently goes to sleep at 0400-0500 and awakens at 0900-1000 hrs and never feeling fully rested. He will start this week working form 1430-2300. Overall he states that his major health concerns are hypogonadism with decrease testosterone and fatigue; Symptoms: Anxiety, Erythema, Swelling, Fatigue, Malaise >60 Days.
Patient complained of dizziness,nausea ,sweating and fever which lasted for about 2minutes(hot flashes). He was asked to sit down while EMS is being activated and the pharmacist kept an eye on him as he was recuperating  EMS(911) was invited and they arrived about 3.11pm. By that time patient has  recovered from those reactions and was waiting for EMS to arrive. EMS arrived and took his vitals and asked him how he is feeling. He acknowledged that he is fine and after a couple of minutes he stood up and walked away with the EMS staff
Hives with itching on inner upper arms and some on belly.  Took Benadryl before going to bed.  Slight unraised red marks without itching remain this morning.
Knot in arm at injection site, rash at injection site to just above elbow, warm to the touch, itching, headache
pt had a neg titer for mump following vax w/MMR; f/u info revealed that the test performed was for complement-fixation rather than an IGG test for mumps; pt was not available for retesting; therefore, no further details are available
Perfuse sweating, blacking out, nausea, heart palpitations, right groin and right lower back pains.  Low blood pressure continued into the next calendar day.   Tallor and headache.